Physical Activity in Promoting Smoking Cessation in African Americans
NCT ID: NCT01915810
Last Updated: 2026-01-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
45 participants
INTERVENTIONAL
2014-01-29
2027-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Increasing Physical Activity as Part of a Smoking Cessation Program
NCT00403312
Quit and Fit: A Tobacco Cessation and Energy Balance Pilot for African Americans
NCT02103582
Computer-Assisted Counseling in Helping African American Smokers Stop Smoking
NCT00310141
Path2Quit Tobacco Intervention For African Americans
NCT03524482
Community-based Smoking Cessation Treatment for Adults With High Stress Sensitivity.
NCT06053567
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. Evaluate the feasibility of a Smoking Cessation with Physical Activity (SCwPA) intervention among an African American (AA) church-based sample of adult current smokers.
II. Conduct post-intervention focus groups to obtain feedback from pilot participants regarding the acceptability of the SCwPA project design and procedures.
III. Examine how physical activity (PA) and the timing of PA initiation affects the mechanisms underlying cessation among an AA church-based sample of adult daily smokers who are attempting to quit.
OUTLINE: Participants are randomized to 1 of 3 arms.
ARM I (PRE-QUIT PHYSICAL ACTIVITY): Participants receive telephone-based cessation counseling over 15-20 minutes 1-2 weeks before assigned quit date and nicotine patch for 6 weeks. Beginning 2 weeks before the assigned quit date, participants receive a Walking Program guide and engage in the SCwPA comprising brisk, self-paced walking with a goal of 150 minutes of exercise activity per week for 5 weeks.
ARM II (QUIT DAY PHYSICAL ACTIVITY): Participants receive telephone-based cessation counseling over 15-20 minutes 1-2 weeks before assigned quit date and nicotine patch for 6 weeks. Beginning on the assigned quit date, participants receive a Walking Program guide and engage in the SCwPA comprising brisk, self-paced walking with a goal of 150 minutes of exercise per week for 5 weeks.
ARM III (NO PHYSICAL ACTIVITY): Participants quit smoking on an assigned date and receive telephone-based cessation counseling over 15-20 minutes 1-2 weeks before assigned quit date and nicotine patch for 6 weeks.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm I (pre-quit physical activity)
Participants receive telephone-based cessation counseling over 15-20 minutes 1-2 weeks before assigned quit date and nicotine patch for 6 weeks. Beginning 2 weeks before the assigned quit date, participants receive a Walking Program guide and engage in the SCwPA comprising brisk, self-paced walking with a goal of 150 minutes of exercise activity per week for 5 weeks.
Exercise Intervention
Complete SCwPA intervention
Laboratory Biomarker Analysis
Correlative studies
Nicotine Patch
Receive nicotine patch
Questionnaire Administration
Ancillary studies
Tobacco Cessation Counseling
Receive smoking cessation counseling
Arm II (quit day physical activity)
Participants receive telephone-based cessation counseling over 15-20 minutes 1-2 weeks before assigned quit date and nicotine patch for 6 weeks. Beginning on the assigned quit date, participants receive a Walking Program guide and engage in the SCwPA comprising brisk, self-paced walking with a goal of 150 minutes of exercise per week for 5 weeks.
Exercise Intervention
Complete SCwPA intervention
Laboratory Biomarker Analysis
Correlative studies
Nicotine Patch
Receive nicotine patch
Questionnaire Administration
Ancillary studies
Tobacco Cessation Counseling
Receive smoking cessation counseling
Arm III (no physical activity)
Participants quit smoking on an assigned date and receive telephone-based cessation counseling over 15-20 minutes 1-2 weeks before assigned quit date and nicotine patch for 6 weeks.
Laboratory Biomarker Analysis
Correlative studies
Nicotine Patch
Receive nicotine patch
Questionnaire Administration
Ancillary studies
Tobacco Cessation Counseling
Receive smoking cessation counseling
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise Intervention
Complete SCwPA intervention
Laboratory Biomarker Analysis
Correlative studies
Nicotine Patch
Receive nicotine patch
Questionnaire Administration
Ancillary studies
Tobacco Cessation Counseling
Receive smoking cessation counseling
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Current daily smoker (has smoked \>= 100 cigarettes in lifetime per self-report, smoked \>= 5 cigarettes per day for the last 6 months per self-report)
* Self-reports motivation to quit smoking within the next 2 weeks
* Reports willingness to engage in a physical activity-based smoking cessation intervention
* Has a home address and a functioning home and/or cell phone number
* Able to engage in moderate intensity physical activity as determined by the Physical Activity Readiness Questionnaire (PAR-Q) or by physicians clearance (letter from physician or nurse practitioner) if currently taking medication for blood pressure or diabetes
* Willingness to wear the nicotine patches provided in the study as recommended
* Have an expired carbon monoxide (CO) level \> 8 parts per million (ppm) suggestive of current smoking
* Blood pressure =\< 140/90mm or by physicians clearance (letter from physician or nurse practitioner) if blood pressure reading \> 140/90mm Hg
Exclusion Criteria
* Regular use of tobacco products other than cigarettes in the last 30 days (including black \& milds)
* Current or planned future use of any nicotine replacement or pharmacological product for smoking cessation other than the study patches
* Pregnancy or lactation
* Another household member enrolled in the study
* A schedule not accommodating to the study procedures, or unwillingness to adhere to the procedures
21 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lorna McNeill
Role: PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
M D Anderson Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
University of Texas MD Anderson Cancer Center Website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2015-01057
Identifier Type: REGISTRY
Identifier Source: secondary_id
2013-0183
Identifier Type: OTHER
Identifier Source: secondary_id
2013-0183
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.